Safety of long-distance transfers of patients on acute mechanical circulatory support

Kang, Tae Soo; Ko, Byung-Soo; Drakos, Stavros G.; Stehlik, Josef; Bott, Steven; Koliopoulou, Antigone; Tonna, Joseph E.; Bowen, Megan E.; Stoddard, Kathleen; Selzman, Craig H.; McKellar, Stephen H.

doi:10.1016/j.jss.2017.11.037

Cited by 11 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Kang, et al in their study reported a case series of the Impella transportation in the US mountainous area. 5) The transport distance was 585 ± 264 (range: 238-1128) km, and they used fixedwing aircrafts with transfer time of 170 ± 29 minutes. Travel from Toyama to Tokyo also required crossing of the high mountains, but we transported similar distance by car.…”

Section: Discussionmentioning

confidence: 99%

“…1) Impella can be inserted percutaneously and directly unloads the left ventricle, and it has been reported as a useful temporary MCS for bridging to HTx or durable LVAD. 2,3) Successful experiences of transportation with Impella over long distance have already been reported in Canada or the US, 4,5) but never to date in Japan. Here, we present the first case of a patient who was safely transported with Impella 5.0 over 450 km in Japan.…”

mentioning

confidence: 99%

See 1 more Smart Citation

First Experience of Transfer with Impella 5.0 Over the Long Distance in Japan

2019

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

First Experience of Transfer with Impella 5.0 Over the Long Distance in Japan

2019

View full text Add to dashboard Cite

show abstract

“…Charon’s 2 group showed the feasibility of long-distance medical evacuation from the remote region of Reunion Island to tertiary centres able to provide heart transplantation in France. Kang 13 reported his valuable experience with fixed-wing aircraft transport across the USA. In addition to the remarkable long distance covered with no adverse in-transit events, his group reported the first positive experience of two patients transported by ECPELLA.…”

Section: Mechanical Circulatory Support Long-distance Transfermentioning

confidence: 99%

The challenge of advanced therapies in the contemporary era: first in Europe ECPELLA long-distance transfer—a case report

Fiorelli,

Panoulas,

Riesgo Gil

et al. 2024

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Background The use of mechanical circulatory support (MCS) has markedly increased over the last decade, so have the inter-hospital transfers, with the aim of being able to offer advanced heart failure (AHF) therapies and centralising patients to tertiary centres. Case summary In this article, we present the first in Europe long-distance air transfer of a patient supported by Veno-Arterial Extracorporeal Membrane Oxygenator and Impella (ECPELLA), as a bridge to successful heart transplant. In our case report, a foreign young patient with AHF due to familiar cardiomyopathy required multiple MCS devices to achieve cardiovascular stability. After appropriate planning and multidisciplinary discussion, the patient was transferred on MCS to his country of origin via a fixed-wing airplane, in order to be assessed for heart transplantation. During take-off the Impella flows temporarily dropped and a suction alarm was displayed; however, this rectified without intervention and the rest of the flight was uneventful. One month after transfer, the patient underwent successful heart transplantation and remained clinically stable during the 12-month follow-up. Discussion Our experience links together the current challenges in the evolving AHF strategies and the increased need for inter-facility cooperation. Both these clinical and logistic challenges appear to lead to possible improved outcomes, after appropriate assessment, training and accurate planning. Our experience provides useful information on feasibility of long-distance transport of patients supported by ECPELLA in Europe.

show abstract

“…Einzelfallberichte über längere Verlegungen von Patienten mit Impella, insbesondere in Ambulanzjets, sind selten. Unserer Erkenntnis nach handelt es sich bei o. g. Patienten um die weltweit erste Transkontinentalverlegung eines Impella-Patienten mit einer Entfernung > 11 000 km und einer Flugzeit von 26 Stunden [6]. Da solch lange Transporte mit einem erhöhten Risiko einhergehen, sollten sie, wie in unserem Fall, immer nur als Ultima Ratio in Betracht kommen.…”

Section: Exkurs Flugphysiologieunclassified

Über Grenzen hinaus: erste Extrem-Langzeit-Impella-Unterstützung mit transkontinentaler Verlegung

Fitzner,

Fühner,

Franke

2023

NOTARZT

View full text Add to dashboard Cite

ZusammenfassungWir berichten über die erste transkontinentale Ambulanzjet-Verlegung eines 61-jährigen Patienten mit über 76 Tage liegender Impella CP-Pumpe nach kardiogenem Schock infolge eines akuten Myokardinfarkts. Nach initialer, diagnostischer Herzkatheteruntersuchung erfolgte, vor einer Hochrisiko-PCI, zunächst die Implantation einer IABP. 15 Tage später wurde auf eine Impella CP-Pumpe gewechselt, die nach 24 Tagen, aufgrund eines technischen Defekts, gewechselt werden musste. Seitdem befindet sich der Patient seit über 76 Tagen an einer Impella CP, was unserer Erkenntnis nach die weltweit längste dokumentierte Liegedauer ist. Aufgrund einer Kolonblutung unter der heparinversetzten Spülflüssigkeit der Impella und der DAPT musste die Antikoagulation mit Heparin gestoppt und stattdessen eine alternative Spüllösung mit Dextrose 5% und Natriumbicarbonat eingesetzt werden. Nach 3-monatigem stationären Aufenthalt erfolgte die Verlegung des Patienten aus den UAE in die USA zur Implantation eines dauerhaften LVAD. Dies ist die erste Transkontinentalverlegung eines Impella-Patienten in einem Ambulanzjet mit einer Entfernung > 11000 km.

show abstract

Safety of long-distance transfers of patients on acute mechanical circulatory support

Cited by 11 publications

References 11 publications

First Experience of Transfer with Impella 5.0 Over the Long Distance in Japan

First Experience of Transfer with Impella 5.0 Over the Long Distance in Japan

The challenge of advanced therapies in the contemporary era: first in Europe ECPELLA long-distance transfer—a case report

Über Grenzen hinaus: erste Extrem-Langzeit-Impella-Unterstützung mit transkontinentaler Verlegung

Contact Info

Product

Resources

About